http://m-l-m.info/?page_id=2701
http://drsircus.com/medicine/deta-elis-star-trek-medicine-bioresonance
http://drsircus.com/medicine/tumor-treating-fields-adding-deta-elis-to-ones-cancer-program
http://rifemachineblog.net/latest-from-john/
http://www.drloyd.com/freq_reverse.pdf
http://www.dnafrequencies.com/about.shtml
http://www.dragonfly75.com/eng/freq-list.html
http://de.scribd.com/doc/105505091/Rife-Frequency-Table-Master-List
Anthony Holland announced a
breakthrough in Rife Research
NOVOBIOTRONICS DELIVERS MAJOR BLOW AGAINST MRSA
WITH RIFE-BARE PLASMA DEVICE
NEW POTENTIAL DRUG-FREE ELECTRONIC TREATMENT FOR ANTIBIOTIC RESISTANT INFECTIONS DISCOVERED BY NOVOBIOTRONICS INC.
Novobiotronics Inc., a nonprofit educational and scientific research company headquartered in upstate New York, has announced a major breakthrough in the fight against dangerous antibiotic resistant strains of bacteria including the ‘superbug’ fatal menace of MRSA, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa, or PS.
Anthony Holland, President of Novobiotronics Inc., Saratoga Springs, NY, was proud to announce the results of laboratory experiments by Novobiotronics in collaboration with the State University of New York throughout 2011 & 2012, that indicate that a 'Rife-Bare Plasma Device' was highly effective against antibiotic resistant PS and MRSA, having both a ‘bacteriostatic’ effect (the growth rate of the deadly strain was tremendously slowed) as well as a bactericidal effect (it kills the bacteria) when used in conjunction with tiny amounts of standard antibiotics to which the deadly organisms are otherwise normally resistant.
According to the US Center for Disease Control and Prevention, nearly 90,000 people die each year in the United States from antibiotic-resistant bacterial infections, more deaths than breast cancer and prostrate cancer combined. MRSA is now “endemic, and even epidemic in many US hospitals”. From 1999 through 2005, MRSA-related hospitalizations more than doubled from 127,036 to 278,203. It appears that more people in the U.S. now die from the mostly hospital-acquired staph infection MRSA than from AIDS. In addition to deadly MRSA outbreaks in communities across the country, of the two million hospital acquired infections each year, 10% are caused by the antibiotic resistant Pseudomonas (PS), which can often lead to life threatening intensive care unit (ICU) pneumonia and other serious medical conditions.
The current mainstream medical treatment of antibiotic resistant bacterial infections has been to use different types of antibiotics in combinations, but many of the newer and more powerful antibiotics have very serious and even dangerous side effects. Doctors even induce some patients into a coma due to the severity of the drug side effects.
Novobiotronics’ new discovery involves the use of a RIFE-BARE DEVICE, invented by Dr. James Bare of Albuquerque, New Mexico, which utilizes a ‘plasma antenna’, a special type of a helium gas filled fluorescent light, which is used to broadcast oscillating pulsed electric fields at the bacteria. These oscillating pulsed electric fields (OPEF) slow the growth rate of the bacteria tremendously and when used in conjunction with tiny amounts of a standard antibiotic, actually nullify the bacteria’s ability to resist antibiotics and have demonstrated an ability to kill the deadly MRSA and PS bacteria in vitro. Novobiotronics’ collaborators from the State University of New York presented their joint findings at the 113th General Meeting of the American Society for Microbiology May 18-21, 2013 in Denver, Colorado.
Related links:
Novobiotronics/SUNY Presentation:
http://www.abstractsonline.com/Plan/...F312E144DB4%7d
Is part of these overall sessions at the 113th General Meeting of the American Society for Microbiology (ASM):
http://www.abstractsonline.com/Plan/...F312E144DB4%7d
Novobiotronics Inc.
http://novobiotronics.com/
anthonyholland@novobiotronics.com
cell: 518-526-2278
Discuss here: http://www.rifeforum.com/forum/showthread.php?t=5228
NOVOBIOTRONICS DELIVERS MAJOR BLOW AGAINST MRSA
WITH RIFE-BARE PLASMA DEVICE
NEW POTENTIAL DRUG-FREE ELECTRONIC TREATMENT FOR ANTIBIOTIC RESISTANT INFECTIONS DISCOVERED BY NOVOBIOTRONICS INC.
Novobiotronics Inc., a nonprofit educational and scientific research company headquartered in upstate New York, has announced a major breakthrough in the fight against dangerous antibiotic resistant strains of bacteria including the ‘superbug’ fatal menace of MRSA, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa, or PS.
Anthony Holland, President of Novobiotronics Inc., Saratoga Springs, NY, was proud to announce the results of laboratory experiments by Novobiotronics in collaboration with the State University of New York throughout 2011 & 2012, that indicate that a 'Rife-Bare Plasma Device' was highly effective against antibiotic resistant PS and MRSA, having both a ‘bacteriostatic’ effect (the growth rate of the deadly strain was tremendously slowed) as well as a bactericidal effect (it kills the bacteria) when used in conjunction with tiny amounts of standard antibiotics to which the deadly organisms are otherwise normally resistant.
According to the US Center for Disease Control and Prevention, nearly 90,000 people die each year in the United States from antibiotic-resistant bacterial infections, more deaths than breast cancer and prostrate cancer combined. MRSA is now “endemic, and even epidemic in many US hospitals”. From 1999 through 2005, MRSA-related hospitalizations more than doubled from 127,036 to 278,203. It appears that more people in the U.S. now die from the mostly hospital-acquired staph infection MRSA than from AIDS. In addition to deadly MRSA outbreaks in communities across the country, of the two million hospital acquired infections each year, 10% are caused by the antibiotic resistant Pseudomonas (PS), which can often lead to life threatening intensive care unit (ICU) pneumonia and other serious medical conditions.
The current mainstream medical treatment of antibiotic resistant bacterial infections has been to use different types of antibiotics in combinations, but many of the newer and more powerful antibiotics have very serious and even dangerous side effects. Doctors even induce some patients into a coma due to the severity of the drug side effects.
Novobiotronics’ new discovery involves the use of a RIFE-BARE DEVICE, invented by Dr. James Bare of Albuquerque, New Mexico, which utilizes a ‘plasma antenna’, a special type of a helium gas filled fluorescent light, which is used to broadcast oscillating pulsed electric fields at the bacteria. These oscillating pulsed electric fields (OPEF) slow the growth rate of the bacteria tremendously and when used in conjunction with tiny amounts of a standard antibiotic, actually nullify the bacteria’s ability to resist antibiotics and have demonstrated an ability to kill the deadly MRSA and PS bacteria in vitro. Novobiotronics’ collaborators from the State University of New York presented their joint findings at the 113th General Meeting of the American Society for Microbiology May 18-21, 2013 in Denver, Colorado.
Related links:
Novobiotronics/SUNY Presentation:
http://www.abstractsonline.com/Plan/...F312E144DB4%7d
Is part of these overall sessions at the 113th General Meeting of the American Society for Microbiology (ASM):
http://www.abstractsonline.com/Plan/...F312E144DB4%7d
Novobiotronics Inc.
http://novobiotronics.com/
anthonyholland@novobiotronics.com
cell: 518-526-2278
Discuss here: http://www.rifeforum.com/forum/showthread.php?t=5228
http://altered-states.net/index2.php?/rife/rifefreq2.htm
No comments:
Post a Comment